Challenge #2. Stagnation in the market
The second significant challenge for pharmaceutical marketing is market stagnation. This is clearly evident when working with different markets, especially in the context of my work with 33 countries. There is a tendency that Ukrainian companies, which once held leading positions in the regional market, are now practically absent from potential partners. This is due to the fact that none of them can provide the necessary level of service and innovation that companies in this sector need.
The reason for this is the lag of the Ukrainian digital bulgaria telegram data market from the global one, which previously was only 3-6 months. This lag is due to the fact that certain tools, such as Google, Facebook, Instagram, were previously not available in Ukraine due to its status as a small market. It is also worth noting that at the global market level, Ukraine was defined as a developed market, but there was a slight lag, which led to certain difficulties.
However, in the last year and a half, Ukraine's lag from global trends has increased, and if the war continues, this trend may worsen. Specific industries, such as data development and processing, analytics, may maintain their positioning, but the overall situation in marketing initiatives is disappointing.
Challenge #3. Reducing expenses
The third major challenge for pharmaceutical marketing is cost reduction. Even with relatively small losses compared to other players in the market, the pharmaceutical category faces the challenge of cost reduction.